Loring Wolcott & Coolidge Fiduciary Advisors’s Zoetis ZTS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $886K | Sell |
12,327
-2,939
| -19% | -$277K | 0.01% | 191 |
|
|
2026
Q1 | $1.8M | Sell |
15,266
-8,682
| -36% | -$1.07M | 0.02% | 126 |
|
|
2025
Q4 | $2.99M | Sell |
23,948
-4,340
| -15% | -$566K | 0.03% | 107 |
|
|
2025
Q3 | $4.14M | Sell |
28,288
-1,349
| -5% | -$204K | 0.04% | 92 |
|
|
2025
Q2 | $4.62M | Sell |
29,637
-345
| -1% | -$54.7K | 0.04% | 91 |
|
|
2025
Q1 | $4.52M | Sell |
29,982
-2,410
| -7% | -$401K | 0.04% | 89 |
|
|
2024
Q4 | $5.6M | Sell |
32,392
-85
| -0.3% | -$15.2K | 0.05% | 92 |
|
|
2024
Q3 | $5.89M | Sell |
32,477
-34
| -0.1% | -$6.26K | 0.05% | 91 |
|
|
2024
Q2 | $5.95M | Buy |
32,511
+906
| +3% | +$151K | 0.05% | 83 |
|
|
2024
Q1 | $4.6M | Buy |
31,605
+2,626
| +9% | +$492K | 0.05% | 85 |
|
|
2023
Q4 | $5.44M | Sell |
28,979
-318
| -1% | -$56.3K | 0.05% | 80 |
|
|
2023
Q3 | $4.71M | Sell |
29,297
-29
| -0.1% | -$5.26K | 0.05% | 80 |
|
|
2023
Q2 | $5.05M | Buy |
29,326
+871
| +3% | +$151K | 0.05% | 81 |
|
|
2023
Q1 | $4.74M | Buy |
28,455
+280
| +1% | +$45.9K | 0.05% | 84 |
|
|
2022
Q4 | $4.13M | Sell |
28,175
-405
| -1% | -$59.9K | 0.05% | 87 |
|
|
2022
Q3 | $4.24M | Hold |
28,580
| – | – | 0.06% | 84 |
|
|
2022
Q2 | $4.91M | Buy |
28,580
+1,084
| +4% | +$187K | 0.06% | 82 |
|
|
2022
Q1 | $5.18M | Buy |
27,496
+648
| +2% | +$128K | 0.05% | 89 |
|
|
2021
Q4 | $6.55M | Buy |
26,848
+376
| +1% | +$82.4K | 0.06% | 85 |
|
|
2021
Q3 | $5.14M | Buy |
26,472
+194
| +0.7% | +$39.1K | 0.05% | 88 |
|
|
2021
Q2 | $4.9M | Buy |
26,278
+1,381
| +6% | +$240K | 0.05% | 89 |
|
|
2021
Q1 | $3.92M | Buy |
24,897
+1,409
| +6% | +$223K | 0.04% | 94 |
|
|
2020
Q4 | $3.89M | Buy |
23,488
+153
| +0.7% | +$24.9K | 0.04% | 94 |
|
|
2020
Q3 | $3.86M | Buy |
23,335
+1,046
| +5% | +$161K | 0.05% | 88 |
|
|
2020
Q2 | $3.05M | Buy |
22,289
+4,873
| +28% | +$636K | 0.04% | 97 |
|
|
2020
Q1 | $2.05M | Buy |
17,416
+915
| +6% | +$120K | 0.03% | 101 |
|
|
2019
Q4 | $2.18M | Buy |
16,501
+3,502
| +27% | +$435K | 0.03% | 113 |
|
|
2019
Q3 | $1.62M | Sell |
12,999
-159
| -1% | -$19.2K | 0.02% | 125 |
|
|
2019
Q2 | $1.49M | Buy |
13,158
+4,207
| +47% | +$441K | 0.02% | 131 |
|
|
2019
Q1 | $901K | Hold |
8,951
| – | – | 0.01% | 160 |
|
|
2018
Q4 | $766K | Buy |
8,951
+2,123
| +31% | +$191K | 0.01% | 168 |
|
|
2018
Q3 | $625K | Buy |
6,828
+255
| +4% | +$22.6K | 0.01% | 190 |
|
|
2018
Q2 | $560K | Buy |
6,573
+400
| +6% | +$33.8K | 0.01% | 194 |
|
|
2018
Q1 | $516K | Hold |
6,173
| – | – | 0.01% | 198 |
|
|
2017
Q4 | $445K | Buy |
6,173
+935
| +18% | +$64.2K | 0.01% | 209 |
|
|
2017
Q3 | $334K | Buy |
5,238
+2,585
| +97% | +$162K | 0.01% | 230 |
|
|
2017
Q2 | $166K | Hold |
2,653
| – | – | ﹤0.01% | 290 |
|
|
2017
Q1 | $142K | Hold |
2,653
| – | – | ﹤0.01% | 310 |
|
|
2016
Q4 | $142K | Sell |
2,653
-762
| -22% | -$38.7K | ﹤0.01% | 304 |
|
|
2016
Q3 | $178K | Hold |
3,415
| – | – | ﹤0.01% | 273 |
|
|
2016
Q2 | $162K | Hold |
3,415
| – | – | ﹤0.01% | 276 |
|
|
2016
Q1 | $151K | Hold |
3,415
| – | – | ﹤0.01% | 269 |
|
|
2015
Q4 | $164K | Buy |
3,415
+373
| +12% | +$16.9K | ﹤0.01% | 282 |
|
|
2015
Q3 | $147K | Hold |
3,042
| – | – | ﹤0.01% | 311 |
|
|
2015
Q2 | $147K | Hold |
3,042
| – | – | ﹤0.01% | 311 |
|
|
2015
Q1 | $141K | Hold |
3,042
| – | – | ﹤0.01% | 326 |
|
|
2014
Q4 | $131K | Sell |
3,042
-2,734
| -47% | -$111K | ﹤0.01% | 327 |
|
|
2014
Q3 | $213K | Hold |
5,776
| – | – | 0.01% | 258 |
|
|
2014
Q2 | $186K | Hold |
5,776
| – | – | 0.01% | 285 |
|
|
2014
Q1 | $167K | Hold |
5,776
| – | – | ﹤0.01% | 280 |
|
|
2013
Q4 | $189K | Buy |
5,776
+245
| +4% | +$7.81K | 0.01% | 263 |
|
|
2013
Q3 | $172K | Sell |
5,531
-4
| -0.1% | -$123 | 0.01% | 256 |
|
|
2013
Q2 | $171K | Buy |
+5,535
| New | +$179K | 0.01% | 268 |
|
Other funds holding ZTS
BPC
Loring Wolcott & Coolidge Fiduciary Advisors's ZTS Position: Q2 2026 in Review
Loring Wolcott & Coolidge Fiduciary Advisors reduced its Zoetis (ZTS) stake by 19% in Q2 2026, selling an estimated $277K and leaving 12,327 shares worth $886K. The position accounts for 0.01% of the portfolio, ranked #191.
Loring Wolcott & Coolidge Fiduciary Advisors first reported a position in ZTS in Q2 2013 and has held it in 53 quarters since. The position peaked at $6.55M in Q4 2021. 811 funds tracked by Wall St. Rank hold ZTS as of Q2 2026.
- Loring Wolcott & Coolidge Fiduciary Advisors held 12,327 shares of Zoetis worth $886K as of Q2 2026.
- Loring Wolcott & Coolidge Fiduciary Advisors sold 2,939 Zoetis shares in Q2 2026, an estimated $277K.
- Zoetis made up 0.01% of Loring Wolcott & Coolidge Fiduciary Advisors's portfolio in Q2 2026, its #191 holding.
- Loring Wolcott & Coolidge Fiduciary Advisors first reported a position in Zoetis in Q2 2013 and has held it in 53 quarters since.
- Loring Wolcott & Coolidge Fiduciary Advisors's Zoetis position peaked at $6.55M in Q4 2021.
- 811 funds tracked by Wall St. Rank held Zoetis as of Q2 2026.
Based on Loring Wolcott & Coolidge Fiduciary Advisors's 13F filing for Q2 2026, filed 30 Jul 2026.